174 related articles for article (PubMed ID: 29569084)
21. In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.
Aird RE; Cummings J; Ritchie AA; Muir M; Morris RE; Chen H; Sadler PJ; Jodrell DI
Br J Cancer; 2002 May; 86(10):1652-7. PubMed ID: 12085218
[TBL] [Abstract][Full Text] [Related]
22. Mixed-ligand complexes of ruthenium(II) containing new photoactive or electroactive ligands: synthesis, spectral characterization and DNA interactions.
Ghosh T; Maiya BG; Samanta A; Shukla AD; Jose DA; Kumar DK; Das A
J Biol Inorg Chem; 2005 Aug; 10(5):496-508. PubMed ID: 15981005
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of Ni(II) complexes bearing indole-based thiosemicarbazone ligands for interaction with biomolecules and some biological applications.
Haribabu J; Jeyalakshmi K; Arun Y; Bhuvanesh NSP; Perumal PT; Karvembu R
J Biol Inorg Chem; 2017 Jun; 22(4):461-480. PubMed ID: 27995332
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization, and anticancer activity of a series of ketone-N(4)-substituted thiosemicarbazones and their ruthenium(II) arene complexes.
Su W; Qian Q; Li P; Lei X; Xiao Q; Huang S; Huang C; Cui J
Inorg Chem; 2013 Nov; 52(21):12440-9. PubMed ID: 24143913
[TBL] [Abstract][Full Text] [Related]
25. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
[TBL] [Abstract][Full Text] [Related]
26. Dinuclear Ru
Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H
Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809
[TBL] [Abstract][Full Text] [Related]
28. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
29. synthesis, characterization and in vitro antiamoebic activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazones and their Palladium (II) and Ruthenium (II) complexes.
Singh S; Bharti N; Naqvi F; Azam A
Eur J Med Chem; 2004 May; 39(5):459-65. PubMed ID: 15110972
[TBL] [Abstract][Full Text] [Related]
30. Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.
Kowol CR; Berger R; Eichinger R; Roller A; Jakupec MA; Schmidt PP; Arion VB; Keppler BK
J Med Chem; 2007 Mar; 50(6):1254-65. PubMed ID: 17315858
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterisation and antiamoebic activity of new thiophene-2-carboxaldehyde thiosemicarbazone derivatives and their cyclooctadiene Ru(II) complexes.
Shailendra NS; Bharti N; Gonzalez Garza MT; Cruz-Vega DE; Castro Garza J; Saleem K; Naqvi F; Azam A
Bioorg Med Chem Lett; 2001 Oct; 11(20):2675-8. PubMed ID: 11591499
[TBL] [Abstract][Full Text] [Related]
32. Biological evaluation of new nickel(II) metallates: Synthesis, DNA/protein binding and mitochondrial mediated apoptosis in human lung cancer cells (A549) via ROS hypergeneration and depletion of cellular antioxidant pool.
Kalaivani P; Saranya S; Poornima P; Prabhakaran R; Dallemer F; Vijaya Padma V; Natarajan K
Eur J Med Chem; 2014 Jul; 82():584-99. PubMed ID: 24946146
[TBL] [Abstract][Full Text] [Related]
33. Ruthenium (II) complexes of thiosemicarbazone: synthesis, biosensor applications and evaluation as antimicrobial agents.
Yildirim H; Guler E; Yavuz M; Ozturk N; Kose Yaman P; Subasi E; Sahin E; Timur S
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():1-8. PubMed ID: 25280673
[TBL] [Abstract][Full Text] [Related]
34. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
[TBL] [Abstract][Full Text] [Related]
35. Copper(II) complexes with substituted thiosemicarbazones of thiophene-2-carboxaldehyde: synthesis, characterization and antiamoebic activity against E. histolytica.
Sharma S; Athar F; Maurya MR; Azam A
Eur J Med Chem; 2005 Dec; 40(12):1414-9. PubMed ID: 16129515
[TBL] [Abstract][Full Text] [Related]
36. Nickel (II) complexes of naphthaquinone thiosemicarbazone and semicarbazone: synthesis, structure, spectroscopy, and biological activity.
Afrasiabi Z; Sinn E; Lin W; Ma Y; Campana C; Padhye S
J Inorg Biochem; 2005 Jul; 99(7):1526-31. PubMed ID: 15927263
[TBL] [Abstract][Full Text] [Related]
37. pH and DNA luminescence switching, DNA photocleavage and cytotoxic properties of two thiophene-containing ruthenium(II) complexes.
Zhao XL; Li ZS; Zhang AG; Liu P; Song XM; Wang KZ
Eur J Med Chem; 2014 Nov; 87():10-22. PubMed ID: 25238290
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization and biological evaluation of ruthenium flavanol complexes against breast cancer.
Singh AK; Saxena G; Sahabjada ; Arshad M
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jun; 180():97-104. PubMed ID: 28282562
[TBL] [Abstract][Full Text] [Related]
39. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
[TBL] [Abstract][Full Text] [Related]
40. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K
Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
